These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38972079)

  • 1. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Jun; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
    Heinemann F; Karges J; Gasser G
    Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
    Negi M; Dixit T; Venkatesh V
    Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy with mitochondria-targeted biscyclometallated Ir(III) complexes. Multi-action mechanism and strong influence of the cyclometallating ligand.
    Zafon E; Echevarría I; Barrabés S; Manzano BR; Jalón FA; Rodríguez AM; Massaguer A; Espino G
    Dalton Trans; 2021 Dec; 51(1):111-128. PubMed ID: 34873601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the π-Expansive Ligands in Ruthenium(II) Polypyridyl Complexes: Synthesis, Characterization, and Biological Evaluation for Photodynamic Therapy Applications.
    Pozza MD; Mesdom P; Abdullrahman A; Prieto Otoya TD; Arnoux P; Frochot C; Niogret G; Saubaméa B; Burckel P; Hall JP; Hollenstein M; Cardin CJ; Gasser G
    Inorg Chem; 2023 Nov; 62(45):18510-18523. PubMed ID: 37913550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
    Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
    Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-emissive Ru
    Yagüe C; Echevarría I; Vaquero M; Fidalgo J; Carbayo A; Jalón FA; Lima JC; Moro AJ; Manzano BR; Espino G
    Chemistry; 2020 Sep; 26(53):12219-12232. PubMed ID: 32301532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance.
    Wei L; He X; Zhao D; Kandawa-Shultz M; Shao G; Wang Y
    Eur J Med Chem; 2024 Jan; 264():115985. PubMed ID: 38016298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
    Li A; Turro C; Kodanko JJ
    Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium Complexes with Protic Ligands: Influence of the Position of OH Groups and π Expansion on Luminescence and Photocytotoxicity.
    Oladipupo OE; Prescott MC; Blevins ER; Gray JL; Cameron CG; Qu F; Ward NA; Pierce AL; Collinson ER; Hall JF; Park S; Kim Y; McFarland SA; Fedin I; Papish ET
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
    McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
    Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents.
    He L; Li Y; Tan CP; Ye RR; Chen MH; Cao JJ; Ji LN; Mao ZW
    Chem Sci; 2015 Oct; 6(10):5409-5418. PubMed ID: 29861886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of the electron transfer pathway in photodynamic activity of Ru(II) polypyridyl complexes containing 4,7-diphenyl-1,10-phenanthroline ligands under normoxic and hypoxic conditions.
    Mazuryk O; Janczy-Cempa E; Łagosz J; Rutkowska-Zbik D; Machnicka A; Krasowska A; Pietrzyk P; Stochel G; Brindell M
    Dalton Trans; 2022 Feb; 51(5):1888-1900. PubMed ID: 35018930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phototoxicity of cyclometallated Ir(III) complexes bearing a thio-bis-benzimidazole ligand, and its monodentate analogue, as potential PDT photosensitisers in cancer cell killing.
    Martínez-Alonso M; Jones CG; Shipp JD; Chekulaev D; Bryant HE; Weinstein JA
    J Biol Inorg Chem; 2024 Feb; 29(1):113-125. PubMed ID: 38183420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ir(III) Half-Sandwich Photosensitizers with a π-Expansive Ligand for Efficient Anticancer Photodynamic Therapy.
    Gonzalo-Navarro C; Zafon E; Organero JA; Jalón FA; Lima JC; Espino G; Rodríguez AM; Santos L; Moro AJ; Barrabés S; Castro J; Camacho-Aguayo J; Massaguer A; Manzano BR; Durá G
    J Med Chem; 2024 Feb; 67(3):1783-1811. PubMed ID: 38291666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation.
    Knoll JD; Albani BA; Turro C
    Acc Chem Res; 2015 Aug; 48(8):2280-7. PubMed ID: 26186416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photocytotoxic kinetically stable ruthenium(II)-
    Sayala J; Srivastava E; Kumar P; Shukla N; Kumar A; Patra AK
    Dalton Trans; 2024 Mar; 53(10):4580-4597. PubMed ID: 38349214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.